Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

A stem cell clinic the FDA found to be operating illegally plans to appeal the agency's authority to the Supreme Court. The ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

The Crafoord Prize in Polyarthritis 2025, worth 6 million Swedish kronor, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA. They ...

Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.

Sanofi has removed a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers of Ablynx, ...